FREE Account Opening + No Clearing Fees
Loading...

Delhivery IPO vs Emcure Pharma IPO

Comparision between Delhivery IPO and Emcure Pharma IPO.

IPO Details

Delhivery IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Emcure Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Delhivery IPO is up to ₹5,235.00 Cr whereas the issue size of the Emcure Pharma IPO is . The final issue price of Delhivery IPO is ₹487.00 per share and of Emcure Pharma IPO is .

  Delhivery IPO Emcure Pharma IPO
Face Value ₹1 per share ₹10 per share
Issue Price (Lower) ₹462.00 per share
Issue Price (Upper) ₹487.00 per share
Issue Price (Final) ₹487.00 per share
Discount (Retail)
Discount (Employee) ₹25.00 per share
Market Lot Size 30 shares
Fresh Issue Size
Fresh Issue Size (Amount) up to ₹4,000.00 Cr up to ₹800.00 Cr
OFS Issue Size 1,36,78,839 shares
OFS Issue Size (Amount) up to ₹1,235.00 Cr
Issue Size Total
Issue Size Total (Amount) up to ₹5,235.00 Cr

IPO Timetable

Delhivery IPO opens on May 11, 2022, while Emcure Pharma IPO opens on . The closing date of Delhivery IPO and Emcure Pharma IPO is May 13, 2022, and , respectively.

  Delhivery IPO Emcure Pharma IPO
Anchor Bid Date
Issue Open May 11, 2022
Issue Close May 13, 2022
Basis Of Allotment (Tentative) May 19, 2022
Initiation of Refunds (Tentative) May 20, 2022
Credit of Share (Tentative) May 23, 2022
Listing date (Tentative) May 24, 2022
Anchor Lockin End date 1 Jun 18, 2022
Anchor Lockin End date 2 Aug 17, 2022

Financials

Delhivery IPO P/E ratio is -67.3, as compared to Emcure Pharma IPO P/E ratio of .

  Delhivery IPO Emcure Pharma IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in million)
  31-Dec-21 31-Dec-20 31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 84,294.83 47,847.56 45,977.98 43,573.08 40,625.45
Total Revenue 49,114.06 28,065.29 38,382.91 29,886.29 16,948.74
Profit After Tax -8,911.39 -2,974.92 -4,157.43 -2,689.26 -17,833.04
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in Millions)
  31-March-21 31-March-20 31-March-19
Total Assets 68,073.98 60,040.55 58,104.39
Total Revenue 60,918.06 51,308.60 48,155.90
Profit After Tax 4,185.94 1,006.10 2,029.68
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio -67.3
Market Cap ₹35283.22 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Delhivery IPO retail investors (RII) are offered 1,12,87,878 shares while in Emcure Pharma IPO retail investors are offered 1,12,87,878 shares. Qualified institutional buyers (QIB) are offered 3,38,63,662 shares in Delhivery IPO and in Emcure Pharma IPO.

  Delhivery IPO Emcure Pharma IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 3,38,63,662 shares
NII 1,69,31,818 shares
RII 1,12,87,878 shares
Employee 4,57,665 shares
Others
Total 6,25,41,023 shares

Bids Received (Subscription)

Delhivery IPO subscribed 1.63x in total, whereas Emcure Pharma IPO subscribed .

  Delhivery IPO Emcure Pharma IPO
QIB (times) 2.66x
NII (times) 0.30x
Big NII (times)
Small NII (times)
RII (times) 0.57x
Employee (times) 0.27x
Other (times) 0.00x
Total (times) 1.63x

Comments

Add a public comment...